Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 54.94

-0.3%

11:08 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	1/7/2005 6:07:14 PM
	Read Replies (3) of 52153

American Pharmaceutical's Breast Cancer Drug Wins FDA Approval January 7, 2005 17:31 EST -- American Pharmaceutical Partners Inc. won U.S. Food and Drug Administration approval to sell a new breast cancer drug, developed under the name Abraxane. [From Bloomberg] The short position corresponds to 50 % of the float. And there are no convertibles outstanding to account for any of the float as far as I can see. I believe the shorts can look forward to an interesting Monday. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next